Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (406)	9/20/1999 8:35:00 PM
From: Bob L	Read Replies (1) \| Respond to of 555

I think you have the time line correct. Although no one has come forward who really knows the FDA rules on this, your conclusion that the 60 day clock starts again seems correct to me. After all, the technical action by the FDA was "refusal to file" or something like that. So it seems the same as if CLTR hadn't tried to file at all. Which implies that the refiling will be procedurally the same as a new filing, which means another 60 days. So it seems like we could have word that CLTR has filed before Nov expiration, but can hardly expect any word from FDA. FDA could be nice and not use the full 60 days, but that would seem out of character.